School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Department of Theoretical and Applied Sciences, eCampus University, Novedrate, Italy.
Mol Psychiatry. 2023 Dec;28(12):4977-4994. doi: 10.1038/s41380-023-02139-3. Epub 2023 Jun 30.
Stress is a major risk factor for psychiatric disorders. During and after exposure to stressors, the stress response may have pro- or maladaptive consequences, depending on several factors related to the individual response and nature of the stressor. However, the mechanisms mediating the long-term effects of exposure to stress, which may ultimately lead to the development of stress-related disorders, are still largely unknown. Epigenetic mechanisms have been shown to mediate the effects of the environment on brain gene expression and behavior. MicroRNAs, small non-coding RNAs estimated to control the expression of about 60% of all genes by post-transcriptional regulation, are a fundamental epigenetic mechanism. Many microRNAs are expressed in the brain, where they work as fine-tuners of gene expression, with a key role in the regulation of homeostatic balance, and a likely influence on pro- or maladaptive brain changes. Here we have selected a number of microRNAs, which have been strongly implicated as mediators of the effects of stress in the brain and in the development of stress-related psychiatric disorders. For all of them recent evidence is reported, obtained from rodent stress models, manipulation of microRNAs levels with related behavioral changes, and clinical studies of stress-related psychiatric disorders. Moreover, we have performed a bioinformatic analysis of the predicted brain-expressed target genes of the microRNAs discussed, and found a central role for mechanisms involved in the regulation of synaptic function. The complex regulatory role of microRNAs has suggested their use as biomarkers for diagnosis and treatment response, as well as possible therapeutic drugs. While, microRNA-based diagnostics have registered advancements, particularly in oncology and other fields, and many biotech companies have launched miRNA therapeutics in their development pipeline, the development of microRNA-based tests and drugs for brain disorders is comparatively slower.
压力是精神障碍的一个主要危险因素。在暴露于应激源期间和之后,应激反应可能具有促进或适应不良的后果,这取决于与个体反应和应激源性质相关的几个因素。然而,介导暴露于应激的长期影响的机制,这些影响最终可能导致应激相关障碍的发展,在很大程度上仍然未知。表观遗传机制已被证明介导环境对大脑基因表达和行为的影响。微小 RNA(miRNA)是一种小的非编码 RNA,估计通过转录后调控控制着大约 60%的基因的表达,是一种基本的表观遗传机制。许多 miRNA 在大脑中表达,它们作为基因表达的微调器,在调节体内平衡方面起着关键作用,并且可能对大脑的适应不良变化产生积极或消极的影响。在这里,我们选择了一些 microRNA,它们被强烈认为是介导大脑应激效应和应激相关精神障碍发展的因素。对于所有这些 microRNA,我们都报告了最近的证据,这些证据是从啮齿动物应激模型中获得的,通过相关的行为改变来操纵 microRNA 水平,以及应激相关精神障碍的临床研究。此外,我们对所讨论的 microRNA 的预测脑表达靶基因进行了生物信息学分析,发现了涉及调节突触功能的机制的核心作用。microRNA 的复杂调节作用表明它们可作为诊断和治疗反应的生物标志物,以及可能的治疗药物。虽然基于 microRNA 的诊断已经取得了进展,特别是在肿瘤学和其他领域,并且许多生物技术公司已经在其开发管道中推出了 miRNA 治疗药物,但基于 microRNA 的脑疾病测试和药物的开发相对较慢。